Showing results 1 to 5 of 5
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
An integrated analysis of phase 2,3 SOF and LDV/SOF trials for the treatment of GT6 HCV Infection Proceeding/Conference:Hepatology International | 2016 | 80 | ||
Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB) Proceeding/Conference:Hepatology International | 2015 | 119 | ||
2015 | 198 | |||
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection Journal:New England Journal of Medicine | 2015 | 110 | ||
Sofosbuvir plus ribavirin for 12 16 or 24 weeks results in sustained virologic response over 97% in genotype 1 and 6 HCV infection in Hong Kong Proceeding/Conference:Hepatology International | 2015 | 84 |